Ypsomed AG
🇨🇭Switzerland
Clinical Trials
5
Active:0
Completed:4
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France
Not yet recruiting
- Conditions
- Diabetes Type 1
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Ypsomed AG
- Target Recruit Count
- 125
- Registration Number
- NCT07048795
- Locations
- 🇫🇷
CHU Amiens, Amiens, France
🇫🇷Hôtel Dieu-Pédiatrie, Angers, France
🇫🇷CH Victor Dupouy, Argenteuil, France
YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Completed
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Ypsomed AG
- Target Recruit Count
- 40
- Registration Number
- NCT05096325
- Locations
- 🇩🇪
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany
🇨🇭Universitätsklinik für Diabetologie, Endokrinologie Ernährungsmedizin & Metabolismus, Bern, Switzerland
Extended Wear of a Steel and a Teflon Insulin Infusion Set
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Ypsomed AG
- Target Recruit Count
- 40
- Registration Number
- NCT03683368
- Locations
- 🇩🇪
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany
News
No news found